Low Perception of Obesity as a Pathological Condition Among Italian Cardiologists.
Autor: | Ferrera, Armando, Battistoni, Allegra, Lanza, Oreste, Rossi, Chiara, Tocci, Giuliano, Volpe, Massimo |
---|---|
Předmět: |
OBESITY complications
CARDIOVASCULAR disease prevention PREVENTION of obesity OBESITY treatment STATINS (Cardiovascular agents) THERAPEUTICS CARDIOVASCULAR diseases risk factors HOSPITAL medical staff CARDIOLOGISTS ATTITUDE (Psychology) PHYSICIANS' attitudes HYPERCHOLESTEREMIA RISK assessment WAIST-hip ratio DESCRIPTIVE statistics QUESTIONNAIRES WAIST circumference ATTITUDES toward obesity STUDENT attitudes EPIDEMIOLOGICAL research ANTIOBESITY agents |
Zdroj: | High Blood Pressure & Cardiovascular Prevention; Jul2023, Vol. 30 Issue 4, p351-356, 6p |
Abstrakt: | Introduction: Obesity is not only an important modifiable cardiovascular risk factor but also a chronic disease with relevant consequences on morbidity and mortality in the general population. According to European guidelines, cardiologists must recognize and treat it properly. Aims: To assess perception of obesity as a modifiable pathological condition and the importance to treat it in a real-world sample of cardiologists and residents in cardiology. Methods: A nationwide, web-based, epidemiological survey on the perception of obesity as a disease and as a modifiable cardiovascular risk factors was conducted in 137 medical doctors (cardiologists and residents in cardiology). Participants filled with their answers a questionnaire of 31 questions about perception of obesity and strategies on cardiovascular disease prevention in clinical practice. Results: Of 137 individuals enrolled in our survey only 5 (3.6%) reported to measure waist circumference in their clinical practice and only 3 (2.2%) reported to measure waist-to-hip ratio. One-hundred-twenty participants (87.6%) would not prescribe an anti-obesity drug to a patient with grade II obesity. Sixty-eight (49.6%) participants have never read or heard of a clinical trial on obesity. On the other hand, 134 (97.8%) routinely measured blood pressure in their clinical practice, 129 (94.2%) would prescribe a statin for a hypercholesterolemic patient and 132 (96.4%) subjects have read/heard a clinical trial on type 2 diabetes in their life. Conclusions: Although obesity is a chronic disease and an important modifiable cardiovascular risk factor such as arterial hypertension, hypercholesterolemia, cigarette smoke and diabetes, cardiologists and residents in cardiology substantially underestimate it ignoring that it should be treated as a proper disease. [ABSTRACT FROM AUTHOR] |
Databáze: | Complementary Index |
Externí odkaz: |